1.1 A bill for an act
1.2 relating to cannabis; modifying medical cannabis and cannabis provisions;
1.3 amending Minnesota Statutes 2024, sections 152.22, subdivisions 4, 7, 10, 13;
1.4 152.24; 152.25; 152.26; 152.261; 152.27, subdivisions 2, 7; 152.28, subdivisions
1.5 1, 3; 152.29, subdivisions 1, 2, 3a, 4; 152.31; 152.32, subdivision 2; 152.33,
1.6 subdivisions 1a, 4; 152.35; 152.37; 342.01, subdivisions 9, 47, 54, by adding a
1.7 subdivision; 342.02, subdivision 3; 342.12; 342.14, subdivisions 3, 6; 342.151,
1.8 subdivisions 2, 3; 342.22, subdivision 3; 342.28, subdivisions 1, 8; 342.29,
1.9 subdivisions 1, 7; 342.30, subdivision 1; 342.33, subdivision 1; 342.44, subdivision
1.10 1; 342.46, subdivision 6; 342.52, by adding a subdivision; 342.57, subdivision 2;
1.11 342.59, subdivision 2; 342.61, subdivision 4; 342.63, subdivisions 2, 3, 6; repealing
1.12 Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.01, subdivision 71;
1.13 342.151, subdivision 1.
1.14BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:
1.15 Section 1. Minnesota Statutes 2024, section 152.22, subdivision 4, is amended to read:
1.16 Subd. 4.Health care practitioner."Health care practitioner" means a Minnesota licensed
1.17Minnesota-licensed doctor of medicine, a Minnesota licensed Minnesota-licensed physician
1.18assistant acting within the scope of authorized practice, or a Minnesota licensed
1.19Minnesota-licensed advanced practice registered nurse who has an active license in good
1.20standing and the primary responsibility for the care and treatment of the qualifying medical
1.21condition of a person an individual diagnosed with a qualifying medical condition.
1.22 Sec. 2. Minnesota Statutes 2024, section 152.22, subdivision 7, is amended to read:
1.23 Subd. 7.Medical cannabis manufacturer."Medical cannabis manufacturer" or
1.24"manufacturer" means an entity registered by the commissioner office to cultivate, acquire,
1.25manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis,
1.26delivery devices, or related supplies and educational materials.
1Sec. 2.
25-00281 as introduced02/19/25 REVISOR EB/VJ
SENATE
STATE OF MINNESOTA
S.F. No. 2372NINETY-FOURTH SESSION
(SENATE AUTHORS: DIBBLE)
OFFICIAL STATUSD-PGDATE
Introduction and first reading03/10/2025
Referred to Health and Human Services 2.1 Sec. 3. Minnesota Statutes 2024, section 152.22, subdivision 10, is amended to read:
2.2 Subd. 10.Patient registry number."Patient registry number" means a unique
2.3identification number assigned by the commissioner office to a patient enrolled in the registry
2.4program.
2.5 Sec. 4. Minnesota Statutes 2024, section 152.22, subdivision 13, is amended to read:
2.6 Subd. 13.Registry verification."Registry verification" means the verification provided
2.7by the commissioner office that a patient is enrolled in the registry program and that includes
2.8the patient's name, registry number, and, if applicable, the name of the patient's registered
2.9designated caregiver or parent, legal guardian, or spouse.
2.10 Sec. 5. Minnesota Statutes 2024, section 152.24, is amended to read:
2.11 152.24 FEDERALLY APPROVED CLINICAL TRIALS.
2.12 The commissioner office may prohibit enrollment of a patient in the registry program
2.13if the patient is simultaneously enrolled in a federally approved clinical trial for the treatment
2.14of a qualifying medical condition with medical cannabis. The commissioner office shall
2.15provide information to all patients enrolled in the registry program on the existence of
2.16federally approved clinical trials for the treatment of the patient's qualifying medical condition
2.17with medical cannabis as an alternative to enrollment in the patient registry program.
2.18 Sec. 6. Minnesota Statutes 2024, section 152.25, is amended to read:
2.19 152.25 COMMISSIONER OFFICE DUTIES.
2.20 Subdivision 1.Medical cannabis manufacturer registration.(a) The commissioner
2.21office shall register two in-state manufacturers for the production of all medical cannabis
2.22within the state. A registration agreement between the commissioner office and a
2.23manufacturer is nontransferable. The commissioner office shall register new manufacturers
2.24or reregister the existing manufacturers by December 1 every two years, using the factors
2.25described in this subdivision. The commissioner office shall accept applications after
2.26December 1, 2014, if one of the manufacturers registered before December 1, 2014, ceases
2.27to be registered as a manufacturer. The commissioner's office's determination that no
2.28manufacturer exists to fulfill the duties under sections 152.22 to 152.37 is subject to judicial
2.29review in Ramsey County District Court. Data submitted during the application process are
2.30private data on individuals or nonpublic data as defined in section 13.02 until the
2.31manufacturer is registered under this section. Data on a manufacturer that is registered are
2.32public data, unless the data are trade secret or security information under section 13.37.
2Sec. 6.
25-00281 as introduced02/19/25 REVISOR EB/VJ 3.1 (b) As a condition for registration, a manufacturer must agree to:
3.2 (1) begin supplying medical cannabis to patients by July 1, 2015; and
3.3 (2) comply with all requirements under sections 152.22 to 152.37.
3.4 (c) The commissioner office shall consider the following factors when determining
3.5which manufacturer to register:
3.6 (1) the technical expertise of the manufacturer in cultivating medical cannabis and
3.7converting the medical cannabis into an acceptable delivery method under section 152.22,
3.8subdivision 6;
3.9 (2) the qualifications of the manufacturer's employees;
3.10 (3) the long-term financial stability of the manufacturer;
3.11 (4) the ability to provide appropriate security measures on the premises of the
3.12manufacturer;
3.13 (5) whether the manufacturer has demonstrated an ability to meet the medical cannabis
3.14production needs required by sections 152.22 to 152.37; and
3.15 (6) the manufacturer's projection and ongoing assessment of fees on patients with a
3.16qualifying medical condition.
3.17 (d) If an officer, director, or controlling person of the manufacturer pleads or is found
3.18guilty of intentionally diverting medical cannabis to a person other than allowed by law
3.19under section 152.33, subdivision 1, the commissioner office may decide not to renew the
3.20registration of the manufacturer, provided the violation occurred while the person was an
3.21officer, director, or controlling person of the manufacturer.
3.22 (e) The commissioner office shall require each medical cannabis manufacturer to contract
3.23with an independent laboratory to test medical cannabis produced by the manufacturer. The
3.24commissioner office shall approve the laboratory chosen by each manufacturer and require
3.25that the laboratory report testing results to the manufacturer in a manner determined by the
3.26commissioner office.
3.27 Subd. 1a.Revocation or nonrenewal of a medical cannabis manufacturer
3.28registration.If the commissioner office intends to revoke or not renew a registration issued
3.29under this section, the commissioner office must first notify in writing the manufacturer
3.30against whom the action is to be taken and provide the manufacturer with an opportunity
3.31to request a hearing under the contested case provisions of chapter 14. If the manufacturer
3.32does not request a hearing by notifying the commissioner office in writing within 20 days
3Sec. 6.
25-00281 as introduced02/19/25 REVISOR EB/VJ 4.1after receipt of the notice of proposed action, the commissioner office may proceed with
4.2the action without a hearing. For revocations, the registration of a manufacturer is considered
4.3revoked on the date specified in the commissioner's office's written notice of revocation.
4.4 Subd. 1b.Temporary suspension proceedings.The commissioner office may institute
4.5proceedings to temporarily suspend the registration of a medical cannabis manufacturer for
4.6a period of up to 90 days by notifying the manufacturer in writing if any action by an
4.7employee, agent, officer, director, or controlling person of the manufacturer:
4.8 (1) violates any of the requirements of sections 152.22 to 152.37 or the rules adopted
4.9thereunder;
4.10 (2) permits, aids, or abets the commission of any violation of state law at the
4.11manufacturer's location for cultivation, harvesting, manufacturing, packaging, and processing
4.12or at any site for distribution of medical cannabis;
4.13 (3) performs any act contrary to the welfare of a registered patient or registered designated
4.14caregiver; or
4.15 (4) obtains, or attempts to obtain, a registration by fraudulent means or misrepresentation.
4.16 Subd. 1c.Notice to patients.Upon the revocation or nonrenewal of a manufacturer's
4.17registration under subdivision 1a or implementation of an enforcement action under
4.18subdivision 1b that may affect the ability of a registered patient, registered designated
4.19caregiver, or a registered patient's parent, legal guardian, or spouse to obtain medical cannabis
4.20from the manufacturer subject to the enforcement action, the commissioner office shall
4.21notify in writing each registered patient and the patient's registered designated caregiver or
4.22registered patient's parent, legal guardian, or spouse about the outcome of the proceeding
4.23and information regarding alternative registered manufacturers. This notice must be provided
4.24two or more business days prior to the effective date of the revocation, nonrenewal, or other
4.25enforcement action.
4.26 Subd. 2.Range of compounds and dosages; report.The office shall review and publicly
4.27report the existing medical and scientific literature regarding the range of recommended
4.28dosages for each qualifying condition and the range of chemical compositions of any plant
4.29of the genus cannabis that will likely be medically beneficial for each of the qualifying
4.30medical conditions. The office shall make this information available to patients with
4.31qualifying medical conditions beginning December 1, 2014, and update the information
4.32every three years. The office may consult with the independent laboratory under contract
4.33with the manufacturer or other experts in reporting the range of recommended dosages for
4.34each qualifying medical condition, the range of chemical compositions that will likely be
4Sec. 6.
25-00281 as introduced02/19/25 REVISOR EB/VJ 5.1medically beneficial, and any risks of noncannabis drug interactions. The office shall consult
5.2with each manufacturer on an annual basis on medical cannabis offered by the manufacturer.
5.3The list of medical cannabis offered by a manufacturer shall be published on the Office of
5.4Cannabis Management website.
5.5 Subd. 3.Deadlines.The commissioner office shall adopt rules necessary for the
5.6manufacturer to begin distribution of medical cannabis to patients under the registry program
5.7by July 1, 2015, and have notice of proposed rules published in the State Register prior to
5.8January 1, 2015.
5.9 Subd. 4.Reports.(a) The commissioner office shall provide regular updates to the task
5.10force on medical cannabis therapeutic research and to the chairs and ranking minority
5.11members of the legislative committees with jurisdiction over health and human services,
5.12public safety, judiciary, and civil law Cannabis Advisory Council under section 342.03
5.13regarding: (1) any changes in federal law or regulatory restrictions regarding the use of
5.14medical cannabis or hemp; and (2) the market demand and supply in this state for products
5.15made from hemp that can be used for medicinal purposes.
5.16 (b) The commissioner office may submit medical research based on the data collected
5.17under sections 152.22 to 152.37 to any federal agency with regulatory or enforcement
5.18authority over medical cannabis to demonstrate the effectiveness of medical cannabis for
5.19treating a qualifying medical condition.
5.20 Sec. 7. Minnesota Statutes 2024, section 152.26, is amended to read:
5.21 152.26 RULEMAKING.
5.22 (a) The commissioner office may adopt rules to implement sections 152.22 to 152.37.
5.23Rules for which notice is published in the State Register before January 1, 2015, may be
5.24adopted using the process in section 14.389.
5.25 (b) The commissioner office may adopt or amend rules, using the procedure in section
5.2614.386, paragraph (a), to implement the addition of dried raw cannabis as an allowable form
5.27of medical cannabis under section 152.22, subdivision 6, paragraph (a), clause (4). Section
5.2814.386, paragraph (b), does not apply to these rules.
5.29 Sec. 8. Minnesota Statutes 2024, section 152.261, is amended to read:
5.30 152.261 RULES; ADVERSE INCIDENTS.
5.31 (a) The commissioner of health office shall adopt rules to establish requirements for
5.32reporting incidents when individuals who are not authorized to possess medical cannabis
5Sec. 8.
25-00281 as introduced02/19/25 REVISOR EB/VJ 6.1under sections 152.22 to 152.37 are found in possession of medical cannabis. The rules
6.2must identify professionals required to report, the information they are required to report,
6.3and actions the reporter must take to secure the medical cannabis.
6.4 (b) The commissioner of health office shall adopt rules to establish requirements for law
6.5enforcement officials and health care professionals to report incidents involving an overdose
6.6of medical cannabis to the commissioner of health office.
6.7 (c) Rules must include the method by which the commissioner office will collect and
6.8tabulate reports of unauthorized possession and overdose.
6.9 Sec. 9. Minnesota Statutes 2024, section 152.27, subdivision 2, is amended to read:
6.10 Subd. 2.Office duties.(a) The office shall:
6.11 (1) give notice of the program to health care practitioners in the state who are eligible
6.12to serve as health care practitioners and explain the purposes and requirements of the
6.13program;
6.14 (2) allow each health care practitioner who meets or agrees to meet the program's
6.15requirements and who requests to participate, to be included in the registry program to
6.16collect data for the patient registry;
6.17 (3) provide explanatory information and assistance to each health care practitioner in
6.18understanding the nature of therapeutic use of medical cannabis within program requirements;
6.19 (4) create and provide a certification to be used by a health care practitioner for the
6.20practitioner to certify whether a patient has been diagnosed with a qualifying medical
6.21condition;
6.22 (5) supervise the participation of the health care practitioner in conducting patient
6.23treatment and health records reporting in a manner that ensures stringent security and
6.24record-keeping requirements and that prevents the unauthorized release of private data on
6.25individuals as defined by section 13.02;
6.26 (6) develop safety criteria for patients with a qualifying medical condition as a
6.27requirement of the patient's participation in the program, to prevent the patient from
6.28undertaking any task under the influence of medical cannabis that would constitute negligence
6.29or professional malpractice on the part of the patient; and
6.30 (7) conduct research and studies based on data from health records submitted to the
6.31registry program and submit reports on intermediate or final research results to the legislature
6.32and major scientific journals. The office may contract with a third party to complete the
6Sec. 9.
25-00281 as introduced02/19/25 REVISOR EB/VJ 7.1requirements of this clause. Any reports submitted must comply with section 152.28,
7.2subdivision 2.
7.3 (b) The office may add a delivery method under section 152.22, subdivision 6, upon a
7.4petition from a member of the public or the Cannabis Advisory Council under section 342.03
7.5or as directed by law. If the office wishes to add a delivery method under section 152.22,
7.6subdivision 6, the office must notify the chairs and ranking minority members of the
7.7legislative policy committees having jurisdiction over health and public safety of the addition
7.8and the reasons for its addition, including any written comments received by the office from
7.9the public and any guidance received from the Cannabis Advisory Council under section
7.10342.03, by January 15 of the year in which the office wishes to make the change. The change
7.11shall be effective on August 1 of that year, unless the legislature by law provides otherwise.
7.12 Sec. 10. Minnesota Statutes 2024, section 152.27, subdivision 7, is amended to read:
7.13 Subd. 7.Notice requirements.Patients and registered designated caregivers shall notify
7.14the commissioner office of any address or name change within 30 days of the change having
7.15occurred. A patient or registered designated caregiver is subject to a $100 fine for failure
7.16to notify the commissioner office of the change.
7.17 Sec. 11. Minnesota Statutes 2024, section 152.28, subdivision 1, is amended to read:
7.18 Subdivision 1.Health care practitioner duties.(a) Prior to a patient's enrollment in
7.19the registry program, a health care practitioner shall:
7.20 (1) determine, in the health care practitioner's medical judgment, whether a patient suffers
7.21from a qualifying medical condition, and, if so determined, provide the patient with a
7.22certification of that diagnosis;
7.23 (2) advise patients, registered designated caregivers, and parents, legal guardians, or
7.24spouses who are acting as caregivers of the existence of any nonprofit patient support groups
7.25or organizations;
7.26 (3) provide explanatory information from the office to patients with qualifying medical
7.27conditions, including disclosure to all patients about the experimental nature of therapeutic
7.28use of medical cannabis; the possible risks, benefits, and side effects of the proposed
7.29treatment; the application and other materials from the office; and provide patients with the
7.30Tennessen warning as required by section 13.04, subdivision 2; and
7.31 (4) agree to continue treatment of the patient's qualifying medical condition and report
7.32medical findings to the office.
7Sec. 11.
25-00281 as introduced02/19/25 REVISOR EB/VJ 8.1 (b) Upon notification from the office of the patient's enrollment in the registry program,
8.2the health care practitioner shall:
8.3 (1) participate in the patient registry reporting system under the guidance and supervision
8.4of the office;
8.5 (2) report health records of the patient throughout the ongoing treatment of the patient
8.6to the office in a manner determined by the commissioner office and in accordance with
8.7subdivision 2;
8.8 (3) determine, every three years, if the patient continues to suffer from a qualifying
8.9medical condition and, if so, issue the patient a new certification of that diagnosis; and
8.10 (4) otherwise comply with all requirements developed by the office.
8.11 (c) A health care practitioner may utilize telehealth, as defined in section 62A.673,
8.12subdivision 2, for certifications and recertifications.
8.13 (d) Nothing in this section requires a health care practitioner to participate in the registry
8.14program.
8.15 Sec. 12. Minnesota Statutes 2024, section 152.28, subdivision 3, is amended to read:
8.16 Subd. 3.Advertising restrictions.(a) A health care practitioner shall not publish or
8.17cause to be published any advertisement that:
8.18 (1) contains false or misleading statements about medical cannabis or about the medical
8.19cannabis registry program;
8.20 (2) uses colloquial terms to refer to medical cannabis, such as pot, weed, or grass;
8.21 (3) states or implies the health care practitioner is endorsed by the Department of Health
8.22office or by the medical cannabis registry program;
8.23 (4) includes images of cannabis in its plant or leaf form or of cannabis-smoking
8.24paraphernalia; or
8.25 (5) contains medical symbols that could reasonably be confused with symbols of
8.26established medical associations or groups.
8.27 (b) A health care practitioner found by the commissioner office to have violated this
8.28subdivision is prohibited from certifying that patients have a qualifying medical condition
8.29for purposes of patient participation in the registry program. The commissioner's office's
8.30decision that a health care practitioner has violated this subdivision is a final decision of
8.31the commissioner office and is not subject to the contested case procedures in chapter 14.
8Sec. 12.
25-00281 as introduced02/19/25 REVISOR EB/VJ 9.1 Sec. 13. Minnesota Statutes 2024, section 152.29, subdivision 1, is amended to read:
9.2 Subdivision 1.Manufacturer; requirements.(a) A manufacturer may operate eight
9.3distribution facilities, which may include the manufacturer's single location for cultivation,
9.4harvesting, manufacturing, packaging, and processing but is not required to include that
9.5location. The commissioner office shall designate the geographical service areas to be served
9.6by each manufacturer based on geographical need throughout the state to improve patient
9.7access. A manufacturer shall not have more than two distribution facilities in each
9.8geographical service area assigned to the manufacturer by the commissioner office. A
9.9manufacturer shall operate only one location where all cultivation, harvesting, manufacturing,
9.10packaging, and processing of medical cannabis shall be conducted. This location may be
9.11one of the manufacturer's distribution facility sites. The additional distribution facilities
9.12may dispense medical cannabis and medical cannabis products but may not contain any
9.13medical cannabis in a form other than those forms allowed under section 152.22, subdivision
9.146, and the manufacturer shall not conduct any cultivation, harvesting, manufacturing,
9.15packaging, or processing at the other distribution facility sites. Any distribution facility
9.16operated by the manufacturer is subject to all of the requirements applying to the
9.17manufacturer under sections 152.22 to 152.37, including, but not limited to, security and
9.18distribution requirements.
9.19 (b) A manufacturer may acquire hemp grown in this state from a hemp grower, and may
9.20acquire hemp products produced by a hemp processor. A manufacturer may manufacture
9.21or process hemp and hemp products into an allowable form of medical cannabis under
9.22section 152.22, subdivision 6. Hemp and hemp products acquired by a manufacturer under
9.23this paragraph are subject to the same quality control program, security and testing
9.24requirements, and other requirements that apply to medical cannabis under sections 152.22
9.25to 152.37 and Minnesota Rules, chapter 4770.
9.26 (c) A medical cannabis manufacturer shall contract with a laboratory approved by the
9.27commissioner office, subject to any additional requirements set by the commissioner office,
9.28for purposes of testing medical cannabis manufactured or hemp or hemp products acquired
9.29by the medical cannabis manufacturer as to content, contamination, and consistency to
9.30verify the medical cannabis meets the requirements of section 152.22, subdivision 6. The
9.31cost of laboratory testing shall be paid by the manufacturer.
9.32 (d) The operating documents of a manufacturer must include:
9.33 (1) procedures for the oversight of the manufacturer and procedures to ensure accurate
9.34record keeping;
9Sec. 13.
25-00281 as introduced02/19/25 REVISOR EB/VJ 10.1 (2) procedures for the implementation of appropriate security measures to deter and
10.2prevent the theft of medical cannabis and unauthorized entrance into areas containing medical
10.3cannabis; and
10.4 (3) procedures for the delivery and transportation of hemp between hemp growers and
10.5manufacturers and for the delivery and transportation of hemp products between hemp
10.6processors and manufacturers.
10.7 (e) A manufacturer shall implement security requirements, including requirements for
10.8the delivery and transportation of hemp and hemp products, protection of each location by
10.9a fully operational security alarm system, facility access controls, perimeter intrusion
10.10detection systems, and a personnel identification system.
10.11 (f) A manufacturer shall not share office space with, refer patients to a health care
10.12practitioner, or have any financial relationship with a health care practitioner.
10.13 (g) A manufacturer shall not permit any person to consume medical cannabis on the
10.14property of the manufacturer.
10.15 (h) A manufacturer is subject to reasonable inspection by the commissioner office.
10.16 (i) For purposes of sections 152.22 to 152.37, a medical cannabis manufacturer is not
10.17subject to the Board of Pharmacy licensure or regulatory requirements under chapter 151.
10.18 (j) A medical cannabis manufacturer may not employ any person who is under 21 years
10.19of age or who has been convicted of a disqualifying felony offense. An employee of a
10.20medical cannabis manufacturer must submit a completed criminal history records check
10.21consent form, a full set of classifiable fingerprints, and the required fees for submission to
10.22the Bureau of Criminal Apprehension before an employee may begin working with the
10.23manufacturer. The bureau must conduct a Minnesota criminal history records check and
10.24the superintendent is authorized to exchange the fingerprints with the Federal Bureau of
10.25Investigation to obtain the applicant's national criminal history record information. The
10.26bureau shall return the results of the Minnesota and federal criminal history records checks
10.27to the commissioner office.
10.28 (k) A manufacturer may not operate in any location, whether for distribution or
10.29cultivation, harvesting, manufacturing, packaging, or processing, within 1,000 feet of a
10.30public or private school existing before the date of the manufacturer's registration with the
10.31commissioner office.
10.32 (l) A manufacturer shall comply with reasonable restrictions set by the commissioner
10.33office relating to signage, marketing, display, and advertising of medical cannabis.
10Sec. 13.
25-00281 as introduced02/19/25 REVISOR EB/VJ 11.1 (m) Before a manufacturer acquires hemp from a hemp grower or hemp products from
11.2a hemp processor, the manufacturer must verify that the hemp grower or hemp processor
11.3has a valid license issued by the commissioner of agriculture under chapter 18K.
11.4 (n) Until a state-centralized, seed-to-sale system is implemented that can track a specific
11.5medical cannabis plant from cultivation through testing and point of sale, the commissioner
11.6office shall conduct at least one unannounced inspection per year of each manufacturer that
11.7includes inspection of:
11.8 (1) business operations;
11.9 (2) physical locations of the manufacturer's manufacturing facility and distribution
11.10facilities;
11.11 (3) financial information and inventory documentation, including laboratory testing
11.12results; and
11.13 (4) physical and electronic security alarm systems.
11.14Sec. 14. Minnesota Statutes 2024, section 152.29, subdivision 2, is amended to read:
11.15 Subd. 2.Manufacturer; production.(a) A manufacturer of medical cannabis shall
11.16provide a reliable and ongoing supply of all medical cannabis needed for the registry program
11.17through cultivation by the manufacturer and through the purchase of hemp from hemp
11.18growers.
11.19 (b) All cultivation, harvesting, manufacturing, packaging, and processing of medical
11.20cannabis must take place in an enclosed, locked facility at a physical address provided to
11.21the commissioner office during the registration process.
11.22 (c) A manufacturer must process and prepare any medical cannabis plant material or
11.23hemp plant material into a form allowable under section 152.22, subdivision 6, prior to
11.24distribution of any medical cannabis.
11.25Sec. 15. Minnesota Statutes 2024, section 152.29, subdivision 3a, is amended to read:
11.26 Subd. 3a.Transportation of medical cannabis; transport staffing.(a) A medical
11.27cannabis manufacturer may staff a transport motor vehicle with only one employee if the
11.28medical cannabis manufacturer is transporting medical cannabis to either a certified
11.29laboratory for the purpose of testing or a facility for the purpose of disposal. If the medical
11.30cannabis manufacturer is transporting medical cannabis for any other purpose or destination,
11Sec. 15.
25-00281 as introduced02/19/25 REVISOR EB/VJ 12.1the transport motor vehicle must be staffed with a minimum of two employees as required
12.2by rules adopted by the commissioner office.
12.3 (b) Notwithstanding paragraph (a), a medical cannabis manufacturer that is only
12.4transporting hemp for any purpose may staff the transport motor vehicle with only one
12.5employee.
12.6 (c) A medical cannabis manufacturer may contract with a third party for armored car
12.7services for deliveries of medical cannabis from its production facility to distribution
12.8facilities. A medical cannabis manufacturer that contracts for armored car services remains
12.9responsible for the transportation manifest and inventory tracking requirements in rules
12.10adopted by the commissioner office.
12.11 (d) Department of Health Office staff may transport medical cannabis for the purposes
12.12of delivering medical cannabis and other samples to a laboratory for testing under rules
12.13adopted by the commissioner office and in cases of special investigations when the
12.14commissioner office has determined there is a potential threat to public health. The transport
12.15motor vehicle must be staffed with a minimum of two Department of Health office
12.16employees. The employees must carry with them their Department of Health office
12.17identification card and a transport manifest.
12.18Sec. 16. Minnesota Statutes 2024, section 152.29, subdivision 4, is amended to read:
12.19 Subd. 4.Report.(a) Each manufacturer shall report to the commissioner office on a
12.20monthly basis the following information on each individual patient for the month prior to
12.21the report:
12.22 (1) the amount and dosages of medical cannabis distributed;
12.23 (2) the chemical composition of the medical cannabis; and
12.24 (3) the tracking number assigned to any medical cannabis distributed.
12.25 (b) For transactions involving Tribal medical cannabis program patients, each
12.26manufacturer shall report to the commissioner office on a weekly basis the following
12.27information on each individual Tribal medical cannabis program patient for the week prior
12.28to the report:
12.29 (1) the name of the Tribal medical cannabis program in which the Tribal medical cannabis
12.30program patient is enrolled;
12.31 (2) the amount and dosages of medical cannabis distributed;
12.32 (3) the chemical composition of the medical cannabis distributed; and
12Sec. 16.
25-00281 as introduced02/19/25 REVISOR EB/VJ 13.1 (4) the tracking number assigned to the medical cannabis distributed.
13.2 Sec. 17. Minnesota Statutes 2024, section 152.31, is amended to read:
13.3 152.31 DATA PRACTICES.
13.4 (a) Government data in patient files maintained by the commissioner office and the
13.5health care practitioner, and data submitted to or by a medical cannabis manufacturer, are
13.6private data on individuals, as defined in section 13.02, subdivision 12, or nonpublic data,
13.7as defined in section 13.02, subdivision 9, but may be used for purposes of complying with
13.8chapter 13 and complying with a request from the legislative auditor or the state auditor in
13.9the performance of official duties. The provisions of section 13.05, subdivision 11, apply
13.10to a registration agreement entered between the commissioner office and a medical cannabis
13.11manufacturer under section 152.25.
13.12 (b) Not public data maintained by the commissioner office may not be used for any
13.13purpose not provided for in sections 152.22 to 152.37, and may not be combined or linked
13.14in any manner with any other list, dataset, or database.
13.15 (c) The commissioner office may execute data sharing arrangements with the
13.16commissioner of agriculture to verify licensing, inspection, and compliance information
13.17related to hemp growers and hemp processors under chapter 18K.
13.18Sec. 18. Minnesota Statutes 2024, section 152.32, subdivision 2, is amended to read:
13.19 Subd. 2.Criminal and civil protections.(a) Subject to section 152.23, the following
13.20are not violations under this chapter:
13.21 (1) use or possession of medical cannabis or medical cannabis products by a patient
13.22enrolled in the registry program; possession by a registered designated caregiver or the
13.23parent, legal guardian, or spouse of a patient if the parent, legal guardian, or spouse is listed
13.24on the registry verification; or use or possession of medical cannabis or medical cannabis
13.25products by a Tribal medical cannabis program patient;
13.26 (2) possession, dosage determination, or sale of medical cannabis or medical cannabis
13.27products by a medical cannabis manufacturer, employees of a manufacturer, a Tribal medical
13.28cannabis program manufacturer, employees of a Tribal medical cannabis program
13.29manufacturer, a laboratory conducting testing on medical cannabis, or employees of the
13.30laboratory; and
13.31 (3) possession of medical cannabis or medical cannabis products by any person while
13.32carrying out the duties required under sections 152.22 to 152.37.
13Sec. 18.
25-00281 as introduced02/19/25 REVISOR EB/VJ 14.1 (b) Medical cannabis obtained and distributed pursuant to sections 152.22 to 152.37 and
14.2associated property is not subject to forfeiture under sections 609.531 to 609.5316.
14.3 (c) The commissioner office, members of a Tribal medical cannabis board, the
14.4commissioner's office's or Tribal medical cannabis board's staff, the commissioner's office's
14.5or Tribal medical cannabis board's agents or contractors, and any health care practitioner
14.6are not subject to any civil or disciplinary penalties by the Board of Medical Practice, the
14.7Board of Nursing, or by any business, occupational, or professional licensing board or entity,
14.8solely for participation in the registry program under sections 152.22 to 152.37 or in a Tribal
14.9medical cannabis program. A pharmacist licensed under chapter 151 is not subject to any
14.10civil or disciplinary penalties by the Board of Pharmacy when acting in accordance with
14.11the provisions of sections 152.22 to 152.37. Nothing in this section affects a professional
14.12licensing board from taking action in response to violations of any other section of law.
14.13 (d) Notwithstanding any law to the contrary, the commissioner office, the governor of
14.14Minnesota, or an employee of any state agency may not be held civilly or criminally liable
14.15for any injury, loss of property, personal injury, or death caused by any act or omission
14.16while acting within the scope of office or employment under sections 152.22 to 152.37.
14.17 (e) Federal, state, and local law enforcement authorities are prohibited from accessing
14.18the patient registry under sections 152.22 to 152.37 except when acting pursuant to a valid
14.19search warrant.
14.20 (f) Notwithstanding any law to the contrary, neither the commissioner office nor a public
14.21employee may release data or information about an individual contained in any report,
14.22document, or registry created under sections 152.22 to 152.37 or any information obtained
14.23about a patient participating in the program, except as provided in sections 152.22 to 152.37.
14.24 (g) No information contained in a report, document, or registry or obtained from a patient
14.25under sections 152.22 to 152.37 or from a Tribal medical cannabis program patient may be
14.26admitted as evidence in a criminal proceeding unless independently obtained or in connection
14.27with a proceeding involving a violation of sections 152.22 to 152.37.
14.28 (h) Notwithstanding section 13.09, any person who violates paragraph (e) or (f) is guilty
14.29of a gross misdemeanor.
14.30 (i) An attorney may not be subject to disciplinary action by the Minnesota Supreme
14.31Court, a Tribal court, or the professional responsibility board for providing legal assistance
14.32to prospective or registered manufacturers or others related to activity that is no longer
14.33subject to criminal penalties under state law pursuant to sections 152.22 to 152.37, or for
14Sec. 18.
25-00281 as introduced02/19/25 REVISOR EB/VJ 15.1providing legal assistance to a Tribal medical cannabis program or a Tribal medical cannabis
15.2program manufacturer.
15.3 (j) The following do not constitute probable cause or reasonable suspicion, and shall not
15.4be used to support a search of the person or property of the person possessing or applying
15.5for the registry verification or equivalent, or otherwise subject the person or property of the
15.6person to inspection by any governmental agency:
15.7 (1) possession of a registry verification or application for enrollment in the registry
15.8program by a person entitled to possess a registry verification or apply for enrollment in
15.9the registry program; or
15.10 (2) possession of a verification or equivalent issued by a Tribal medical cannabis program
15.11or application for enrollment in a Tribal medical cannabis program by a person entitled to
15.12possess such a verification or application.
15.13Sec. 19. Minnesota Statutes 2024, section 152.33, subdivision 1a, is amended to read:
15.14 Subd. 1a.Intentional diversion outside the state; penalties.(a) In addition to any other
15.15applicable penalty in law, the commissioner office may levy a fine of $250,000 against a
15.16manufacturer and may immediately initiate proceedings to revoke the manufacturer's
15.17registration, using the procedure in section 152.25, if:
15.18 (1) an officer, director, or controlling person of the manufacturer pleads or is found
15.19guilty under subdivision 1 of intentionally transferring medical cannabis, while the person
15.20was an officer, director, or controlling person of the manufacturer, to a person other than
15.21allowed by law; and
15.22 (2) in intentionally transferring medical cannabis to a person other than allowed by law,
15.23the officer, director, or controlling person transported or directed the transport of medical
15.24cannabis outside of Minnesota.
15.25 (b) All fines collected under this subdivision shall be deposited in the state government
15.26special revenue fund.
15.27Sec. 20. Minnesota Statutes 2024, section 152.33, subdivision 4, is amended to read:
15.28 Subd. 4.Submission of false records; criminal penalty.A person who knowingly
15.29submits false records or documentation required by the commissioner office to register as
15.30a manufacturer of medical cannabis under sections 152.22 to 152.37 is guilty of a felony
15.31and may be sentenced to imprisonment for not more than two years or by payment of a fine
15.32of not more than $3,000, or both.
15Sec. 20.
25-00281 as introduced02/19/25 REVISOR EB/VJ 16.1 Sec. 21. Minnesota Statutes 2024, section 152.35, is amended to read:
16.2 152.35 FEES; DEPOSIT OF REVENUE.
16.3 (a) The commissioner office shall collect an application fee of $20,000 from each entity
16.4submitting an application for registration as a medical cannabis manufacturer. Revenue
16.5from the fee shall be deposited in the state treasury and credited to the state government
16.6special revenue fund.
16.7 (b) The commissioner office shall establish and collect an annual fee from a medical
16.8cannabis manufacturer equal to the cost of regulating and inspecting the manufacturer in
16.9that year. Revenue from the fee amount shall be deposited in the state treasury and credited
16.10to the state government special revenue fund.
16.11 (c) A medical cannabis manufacturer may charge patients enrolled in the registry program
16.12a reasonable fee for costs associated with the operations of the manufacturer. The
16.13manufacturer may establish a sliding scale of patient fees based upon a patient's household
16.14income and may accept private donations to reduce patient fees.
16.15Sec. 22. Minnesota Statutes 2024, section 152.37, is amended to read:
16.16 152.37 FINANCIAL EXAMINATIONS; PRICING REVIEWS.
16.17 Subdivision 1.Financial records.A medical cannabis manufacturer shall maintain
16.18detailed financial records in a manner and format approved by the commissioner office,
16.19and shall keep all records updated and accessible to the commissioner office when requested.
16.20 Subd. 2.Certified annual audit.A medical cannabis manufacturer shall submit the
16.21results of an annual certified financial audit to the commissioner office no later than May
16.221 of each year for the calendar year beginning January 2015. The annual audit shall be
16.23conducted by an independent certified public accountant and the costs of the audit are the
16.24responsibility of the medical cannabis manufacturer. Results of the audit shall be provided
16.25to the medical cannabis manufacturer and the commissioner office. The commissioner office
16.26may also require another audit of the medical cannabis manufacturer by a certified public
16.27accountant chosen by the commissioner office with the costs of the audit paid by the medical
16.28cannabis manufacturer.
16.29 Subd. 3.Power to examine.(a) The commissioner office or designee may examine the
16.30business affairs and conditions of any medical cannabis manufacturer, including but not
16.31limited to a review of the financing, budgets, revenues, sales, and pricing.
16Sec. 22.
25-00281 as introduced02/19/25 REVISOR EB/VJ 17.1 (b) An examination may cover the medical cannabis manufacturer's business affairs,
17.2practices, and conditions including but not limited to a review of the financing, budgets,
17.3revenues, sales, and pricing. The commissioner office shall determine the nature and scope
17.4of each examination and in doing so shall take into account all available relevant factors
17.5concerning the financial and business affairs, practices, and conditions of the examinee.
17.6The costs incurred by the department in conducting an examination shall be paid for by the
17.7medical cannabis manufacturer.
17.8 (c) When making an examination under this section, the commissioner office may retain
17.9attorneys, appraisers, independent economists, independent certified public accountants, or
17.10other professionals and specialists as designees. A certified public accountant retained by
17.11the commissioner office may not be the same certified public accountant providing the
17.12certified annual audit in subdivision 2.
17.13 (d) The commissioner office shall make a report of an examination conducted under this
17.14section and provide a copy to the medical cannabis manufacturer. The commissioner office
17.15shall then post a copy of the report on the department's website. All working papers, recorded
17.16information, documents, and copies produced by, obtained by, or disclosed to the
17.17commissioner office or any other person in the course of an examination, other than the
17.18information contained in any commissioner office official report, made under this section
17.19are private data on individuals or nonpublic data, as defined in section 13.02.
17.20Sec. 23. Minnesota Statutes 2024, section 342.01, subdivision 9, is amended to read:
17.21 Subd. 9.Bona fide labor organization."Bona fide labor organization" means a labor
17.22union that represents or is actively seeking to represent cannabis workers. of:
17.23 (1) a cannabis business; or
17.24 (2) a lower-potency hemp edible manufacturer.
17.25Sec. 24. Minnesota Statutes 2024, section 342.01, subdivision 47, is amended to read:
17.26 Subd. 47.Labor peace agreement."Labor peace agreement" means an agreement
17.27between a cannabis business and a bona fide labor organization or an agreement between
17.28a lower-potency hemp edible manufacturer and a bona fide labor organization that protects
17.29the state's interests by, at minimum, prohibiting the labor organization from engaging in
17.30picketing, work stoppages, or boycotts against the cannabis business or lower-potency hemp
17.31edible manufacturer.
17Sec. 24.
25-00281 as introduced02/19/25 REVISOR EB/VJ 18.1 Sec. 25. Minnesota Statutes 2024, section 342.01, subdivision 54, is amended to read:
18.2 Subd. 54.Medical cannabis flower."Medical cannabis flower" means cannabis flower
18.3provided to a patient enrolled in the registry program or a visiting patient; a registered
18.4designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a
18.5registered designated caregiver, cannabis retailer, or cannabis business with a medical
18.6cannabis retail endorsement to treat or alleviate the symptoms of a qualifying medical
18.7condition. Medical cannabis flower does not include adult-use cannabis flower.
18.8 Sec. 26. Minnesota Statutes 2024, section 342.01, is amended by adding a subdivision to
18.9read:
18.10 Subd. 54a.Medical cannabis paraphernalia."Medical cannabis paraphernalia" means
18.11a delivery device, related supply, or educational material used by a patient enrolled in the
18.12registry program to administer medical cannabis and medical cannabinoid products.
18.13Sec. 27. Minnesota Statutes 2024, section 342.02, subdivision 3, is amended to read:
18.14 Subd. 3.Medical cannabis program.(a) The powers and duties of the Department of
18.15Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections
18.16152.22 to 152.37, are transferred to the Office of Cannabis Management under section
18.1715.039.
18.18 (b) The following protections shall apply to employees who are transferred from the
18.19Department of Health to the Office of Cannabis Management:
18.20 (1) the employment status and job classification of a transferred employee shall not be
18.21altered as a result of the transfer;
18.22 (2) transferred employees who were represented by an exclusive representative prior to
18.23the transfer shall continue to be represented by the same exclusive representative after the
18.24transfer;
18.25 (3) the applicable collective bargaining agreements with exclusive representatives shall
18.26continue in full force and effect for such transferred employees after the transfer;
18.27 (4) the state must meet and negotiate with the exclusive representatives of the transferred
18.28employees about any proposed changes affecting or relating to the transferred employees'
18.29terms and conditions of employment to the extent such changes are not addressed in the
18.30applicable collective bargaining agreement; and
18Sec. 27.
25-00281 as introduced02/19/25 REVISOR EB/VJ 19.1 (5) for an employee in a temporary unclassified position transferred to the Office of
19.2Cannabis Management, the total length of time that the employee has served in the
19.3appointment shall include all time served in the appointment and the transferring agency
19.4and the time served in the appointment at the Office of Cannabis Management. An employee
19.5in a temporary unclassified position who was hired by a transferring agency through an
19.6open competitive selection process in accordance with a policy enacted by Minnesota
19.7Management and Budget shall be considered to have been hired through such process after
19.8the transfer.
19.9 (c) This subdivision is effective July 1, 2024.
19.10Sec. 28. Minnesota Statutes 2024, section 342.12, is amended to read:
19.11 342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
19.12 (a) Licenses issued under this chapter that are available to all applicants pursuant to
19.13section 342.14, subdivision 1b, paragraph (c), may be freely transferred subject to the prior
19.14written approval of the office unless the license holder has not received a final site inspection
19.15or the license holder is a social equity applicant.
19.16 (b) Licenses issued as social equity licenses pursuant to either section 342.14, subdivision
19.171b, paragraph (b), or section 342.175, paragraph (b), may only be transferred to another
19.18social equity applicant for three years after the date on which the office issues the license.
19.19Three years after the date of issuance, a license holder may transfer a license to any entity.
19.20Transfer of a license that was issued as a social equity license must be reviewed by the
19.21Division of Social Equity and is subject to the prior written approval of the office.
19.22 (c) Preliminary license preapproval approval issued pursuant to section 342.125 342.14,
19.23subdivision 5, may not be transferred.
19.24 (d) A new license must be obtained when:
19.25 (1) the form of the licensee's legal business structure converts or changes to a different
19.26type of legal business structure; or
19.27 (2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency,
19.28or receivership proceedings; merges with another legal organization; or assigns all or
19.29substantially all of its assets for the benefit of creditors.
19.30 (e) Licenses must be renewed annually.
19.31 (f) License holders may petition the office to adjust the tier of a license issued within a
19.32license category if the license holder meets all applicable requirements.
19Sec. 28.
25-00281 as introduced02/19/25 REVISOR EB/VJ 20.1 (g) The office by rule may permit the relocation of a licensed cannabis business; permit
20.2the relocation of an approved operational location, including a cultivation, manufacturing,
20.3processing, or retail location; adopt requirements for the submission of a license relocation
20.4application; establish standards for the approval of a relocation application; and charge a
20.5fee not to exceed $250 for reviewing and processing applications. Relocation of a licensed
20.6premises pursuant to this paragraph does not extend or otherwise modify the license term
20.7of the license subject to relocation.
20.8 Sec. 29. Minnesota Statutes 2024, section 342.14, subdivision 3, is amended to read:
20.9 Subd. 3.Review.(a) After an applicant submits an application that contains all required
20.10information and pays the applicable licensing application fee, the office must review the
20.11application.
20.12 (b) The office may deny an application if:
20.13 (1) the application is incomplete;
20.14 (2) the application contains a materially false statement about the applicant or omits
20.15information required under subdivision 1;
20.16 (3) the applicant does not meet the qualifications under section 342.16;
20.17 (4) the applicant is prohibited from holding the license under section 342.18, subdivision
20.182;
20.19 (5) the application does not meet the minimum requirements under section 342.18,
20.20subdivision 3;
20.21 (6) the applicant fails to pay the applicable application fee;
20.22 (7) the application was not submitted by the application deadline;
20.23 (8) the applicant submitted more than one application for a license type; or
20.24 (9) the office determines that the applicant would be prohibited from holding a license
20.25for any other reason.
20.26 (c) If the office denies an application, the office must notify the applicant of the denial
20.27and the basis for the denial.
20.28 (d) The office may request additional information from any applicant if the office
20.29determines that the information is necessary to review or process the application. If the
20.30applicant does not provide the additional requested information within 14 calendar days of
20.31the office's request for information, the office may deny the application.
20Sec. 29.
25-00281 as introduced02/19/25 REVISOR EB/VJ 21.1 (e) An applicant whose application is not denied under this subdivision is a qualified
21.2applicant.
21.3 Sec. 30. Minnesota Statutes 2024, section 342.14, subdivision 6, is amended to read:
21.4 Subd. 6.Completed application; final authorization; issuance of license.(a) Within
21.518 months of receiving notice of preliminary license approval, an applicant must provide:
21.6 (1) the address and legal property description of the location where the business will
21.7operate;
21.8 (2) the name of the local unit of government where the business will be located; and
21.9 (3) if applicable, an updated description of the location where the business will operate,
21.10an updated security plan, and any other additional information required by the office.
21.11 (b) Upon receipt of the information required under paragraph (a) from an applicant that
21.12has received preliminary license approval, the office must:
21.13 (1) forward a copy of the application to the local unit of government in which the business
21.14operates or intends to operate with a form for certification as to whether a proposed cannabis
21.15business complies with local zoning ordinances and, if applicable, whether the proposed
21.16business complies with the state fire code and building code;
21.17 (2) schedule a site inspection; and
21.18 (3) require the applicant to pay the applicable license fee.
21.19 (c) The office may deny final authorization if:
21.20 (1) an applicant fails to submit any required information;
21.21 (2) the applicant submits a materially false statement about the applicant or fails to
21.22provide any required information;
21.23 (3) the office confirms that the cannabis business for which the office granted a
21.24preliminary license preapproval approval does not meet local zoning and land use laws;
21.25 (4) the applicant fails to pay the applicable license fee; or
21.26 (5) the office determines that the applicant is disqualified from holding the license or
21.27would operate in violation of the provisions of this chapter.
21.28 (d) Within 90 days of receiving the information required under paragraph (a) and the
21.29results of any required background check, the office shall grant final authorization and issue
21Sec. 30.
25-00281 as introduced02/19/25 REVISOR EB/VJ 22.1the appropriate license or send the applicant a notice of rejection setting forth specific
22.2reasons that the office did not approve the application.
22.3 Sec. 31. Minnesota Statutes 2024, section 342.151, subdivision 2, is amended to read:
22.4 Subd. 2.Criminal history check.A license holder cannabis business may employ or
22.5contract with as many unlicensed individuals as may be necessary, provided that the license
22.6holder cannabis business is at all times accountable for the good conduct of every individual
22.7employed by or contracted with the license holder cannabis business. Before hiring an
22.8individual as a cannabis worker, the license holder cannabis business must submit to the
22.9Bureau of Criminal Apprehension the individual's full set of fingerprints and written consent
22.10for the bureau to conduct a state and national criminal history check. The bureau may
22.11exchange an individual's fingerprints with the Federal Bureau of Investigation. The Bureau
22.12of Criminal Apprehension must determine whether the individual is qualified to be employed
22.13as a cannabis worker and must notify the license holder cannabis business of the bureau's
22.14determination. The license holder cannabis business must not employ an individual who is
22.15disqualified from being employed as a cannabis worker.
22.16Sec. 32. Minnesota Statutes 2024, section 342.151, subdivision 3, is amended to read:
22.17 Subd. 3.Disqualification.(a) A license holder cannabis business must not employ an
22.18individual as a cannabis worker if the individual has been convicted of any of the following
22.19crimes that would constitute a felony:
22.20 (1) human trafficking;
22.21 (2) noncannabis controlled substance crimes in the first or second degree;
22.22 (3) labor trafficking;
22.23 (4) fraud;
22.24 (5) embezzlement;
22.25 (6) extortion;
22.26 (7) money laundering; or
22.27 (8) insider trading;
22.28if committed in this state or any other jurisdiction for which a full pardon or similar relief
22.29has not been granted.
22Sec. 32.
25-00281 as introduced02/19/25 REVISOR EB/VJ 23.1 (b) A license holder cannabis business must not employ an individual as a cannabis
23.2worker if the individual made any false statement in an application for employment.
23.3 Sec. 33. Minnesota Statutes 2024, section 342.22, subdivision 3, is amended to read:
23.4 Subd. 3.Issuance of registration.(a) A local unit of government shall issue a retail
23.5registration to a cannabis microbusiness with a retail operations endorsement, cannabis
23.6mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis
23.7combination business operating a retail location, or lower-potency hemp edible retailer that:
23.8 (1) has a valid license or preliminary license preapproval approval issued by the office;
23.9 (2) has paid the registration fee or renewal fee pursuant to subdivision 2;
23.10 (3) is found to be in compliance with the requirements of this chapter at any preliminary
23.11compliance check that the local unit of government performs; and
23.12 (4) if applicable, is current on all property taxes and assessments at the location where
23.13the retail establishment is located.
23.14 (b) Before issuing a retail registration, the local unit of government may conduct a
23.15preliminary compliance check to ensure that the cannabis business or hemp business is in
23.16compliance with any applicable local ordinance established pursuant to section 342.13.
23.17 (c) A local unit of government shall renew the retail registration of a cannabis business
23.18or hemp business when the office renews the license of the cannabis business or hemp
23.19business.
23.20 (d) A retail registration issued under this section may not be transferred.
23.21Sec. 34. Minnesota Statutes 2024, section 342.28, subdivision 1, is amended to read:
23.22 Subdivision 1.Authorized actions.A cannabis microbusiness license, consistent with
23.23the specific license endorsement or endorsements, entitles the license holder to perform any
23.24or all of the following within the limits established by this section:
23.25 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
23.26cannabis flower from a mature plant;
23.27 (2) make cannabis concentrate;
23.28 (3) make hemp concentrate, including hemp concentrate with a delta-9
23.29tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
23.30 (4) manufacture artificially derived cannabinoids;
23Sec. 34.
25-00281 as introduced02/19/25 REVISOR EB/VJ 24.1 (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and
24.2hemp-derived consumer products for public consumption;
24.3 (6) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
24.4products, lower-potency hemp edibles, and hemp-derived consumer products from another
24.5cannabis microbusiness, a cannabis mezzobusiness, a cannabis cultivator, a cannabis
24.6manufacturer, or a cannabis wholesaler, or a lower-potency hemp edible manufacturer;
24.7 (7) purchase hemp plant parts and propagules from an industrial hemp grower licensed
24.8under chapter 18K;
24.9 (8) purchase hemp concentrate from an industrial hemp processor licensed under chapter
24.1018K;
24.11 (9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids
24.12from another cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer,
24.13or a cannabis wholesaler for use in manufacturing adult-use cannabis products, lower-potency
24.14hemp edibles, or hemp-derived consumer products;
24.15 (10) package and label adult-use cannabis flower, adult-use cannabis products,
24.16lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
24.17 (11) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
24.18cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
24.19other products authorized by law to other cannabis businesses and to customers;
24.20 (12) operate an establishment that permits on-site consumption of edible cannabis
24.21products and lower-potency hemp edibles; and
24.22 (13) perform other actions approved by the office.
24.23Sec. 35. Minnesota Statutes 2024, section 342.28, subdivision 8, is amended to read:
24.24 Subd. 8.Production of customer consumer products endorsement.A cannabis
24.25microbusiness that manufactures edible cannabis products, lower-potency hemp products,
24.26or hemp-derived consumer products must comply with the requirements in section 342.26,
24.27subdivisions 2 and 4.
24.28Sec. 36. Minnesota Statutes 2024, section 342.29, subdivision 1, is amended to read:
24.29 Subdivision 1.Authorized actions.A cannabis mezzobusiness license, consistent with
24.30the specific license endorsement or endorsements, entitles the license holder to perform any
24.31or all of the following within the limits established by this section:
24Sec. 36.
25-00281 as introduced02/19/25 REVISOR EB/VJ 25.1 (1) grow cannabis plants from seed or immature plant to mature plant and harvest
25.2cannabis flower from a mature plant for use as adult-use cannabis flower or for use in
25.3adult-use cannabis products;
25.4 (2) grow cannabis plants from seed or immature plant to mature plant and harvest
25.5cannabis flower from a mature plant for use as medical cannabis flower or for use in medical
25.6cannabinoid products;
25.7 (3) make cannabis concentrate;
25.8 (4) make hemp concentrate, including hemp concentrate with a delta-9
25.9tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
25.10 (5) manufacture artificially derived cannabinoids;
25.11 (6) manufacture adult-use cannabis products, lower-potency hemp edibles, and
25.12hemp-derived consumer products for public consumption;
25.13 (7) process medical cannabinoid products;
25.14 (8) purchase immature cannabis plants and seedlings and, cannabis flower, cannabis
25.15products, lower-potency hemp edibles, and hemp-derived consumer products from a cannabis
25.16microbusiness, another cannabis mezzobusiness, a cannabis cultivator, a cannabis
25.17manufacturer, or a cannabis wholesaler, or a lower-potency hemp edible manufacturer;
25.18 (9) purchase cannabis concentrate, hemp concentrate, and synthetically artificially derived
25.19cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis
25.20manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products,
25.21lower-potency hemp edibles, or hemp-derived consumer products;
25.22 (10) purchase hemp plant parts and propagules from a licensed hemp grower licensed
25.23under chapter 18K;
25.24 (11) purchase hemp concentrate from an industrial hemp processor licensed under chapter
25.2518K;
25.26 (12) package and label adult-use cannabis flower, adult-use cannabis products,
25.27lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
25.28 (13) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use
25.29cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and
25.30other products authorized by law to other cannabis businesses and to customers; and
25.31 (14) perform other actions approved by the office.
25Sec. 36.
25-00281 as introduced02/19/25 REVISOR EB/VJ 26.1 Sec. 37. Minnesota Statutes 2024, section 342.29, subdivision 7, is amended to read:
26.2 Subd. 7.Production of customer consumer products endorsement.A cannabis
26.3mezzobusiness that manufactures edible cannabis products, lower-potency hemp products,
26.4or hemp-derived consumer products must comply with the requirements in section 342.26,
26.5subdivisions 2 and 4.
26.6 Sec. 38. Minnesota Statutes 2024, section 342.30, subdivision 1, is amended to read:
26.7 Subdivision 1.Authorized actions.A cannabis cultivator license entitles the license
26.8holder to:
26.9 (1) grow cannabis plants within the approved amount of space from seed or immature
26.10plant to mature plant,;
26.11 (2) harvest cannabis flower from a mature plant,;
26.12 (3) package and label immature cannabis plants and seedlings and cannabis flower for
26.13sale to other cannabis businesses,;
26.14 (4) sell immature cannabis plants and seedlings and cannabis flower to other cannabis
26.15businesses;
26.16 (5) transport cannabis flower to a cannabis manufacturer located on the same premises,;
26.17and
26.18 (6) perform other actions approved by the office.
26.19Sec. 39. Minnesota Statutes 2024, section 342.33, subdivision 1, is amended to read:
26.20 Subdivision 1.Authorized actions.A cannabis wholesaler license entitles the license
26.21holder to:
26.22 (1) purchase immature cannabis plants and seedlings, cannabis flower, cannabis products,
26.23lower-potency hemp edibles, and hemp-derived consumer products from cannabis
26.24microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers,
26.25and cannabis microbusinesses lower-potency hemp edible manufacturers;
26.26 (2) purchase hemp plant parts and propagules from industrial hemp growers licensed
26.27under chapter 18K;
26.28 (3) purchase hemp concentrate from an industrial hemp processor licensed under chapter
26.2918K;
26Sec. 39.
25-00281 as introduced02/19/25 REVISOR EB/VJ 27.1 (4) sell immature cannabis plants and seedlings, cannabis flower, cannabis products,
27.2lower-potency hemp edibles, and hemp-derived consumer products to cannabis
27.3microbusinesses, cannabis mezzobusinesses, cannabis manufacturers, and cannabis retailers;
27.4 (5) sell lower-potency hemp edibles to lower-potency hemp edible retailers;
27.5 (6) import hemp-derived consumer products and lower-potency hemp edibles that contain
27.6hemp concentrate or artificially derived cannabinoids that are derived from hemp plants or
27.7hemp plant parts; and
27.8 (7) perform other actions approved by the office.
27.9 Sec. 40. Minnesota Statutes 2024, section 342.44, subdivision 1, is amended to read:
27.10 Subdivision 1.Application; contents.(a) Except as otherwise provided in this
27.11subdivision, the provisions of this chapter relating to license applications, license selection
27.12criteria, general ownership disqualifications and requirements, and general operational
27.13requirements do not apply to hemp businesses.
27.14 (b) The office, by rule, shall establish forms and procedures for the processing of hemp
27.15licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp
27.16license shall include the following information, if applicable:
27.17 (1) the name, address, and date of birth of the applicant;
27.18 (2) the address and legal property description of the business;
27.19 (3) proof of trade name registration;
27.20 (4) certification that the applicant will comply with the requirements of this chapter
27.21relating to the ownership and operation of a hemp business;
27.22 (5) identification of one or more controlling persons or managerial employees as agents
27.23who shall be responsible for dealing with the office on all matters; and
27.24 (6) a statement that the applicant agrees to respond to the office's supplemental requests
27.25for information.
27.26 (c) An applicant for a lower-potency hemp edible manufacturer license must submit an
27.27attestation signed by a bona fide labor organization stating that the applicant has entered
27.28into a labor peace agreement.
27.29 (d) An application on behalf of a corporation or association shall be signed by at least
27.30two officers or managing agents of that entity.
27Sec. 40.
25-00281 as introduced02/19/25 REVISOR EB/VJ 28.1 Sec. 41. Minnesota Statutes 2024, section 342.46, subdivision 6, is amended to read:
28.2 Subd. 6.Compliant products.(a) A lower-potency hemp edible retailer shall ensure
28.3that all lower-potency hemp edibles offered for sale comply with the limits on the amount
28.4and types of cannabinoids that a lower-potency hemp edible can contain, including but not
28.5limited to the requirement that lower-potency hemp edibles:
28.6 (1) consist of servings that contain no more than five milligrams of delta-9
28.7tetrahydrocannabinol, no more than 25 milligrams of cannabidiol, no more than 25 milligrams
28.8of cannabigerol, or any combination of those cannabinoids that does not exceed the identified
28.9amounts;
28.10 (2) do not contain more than a combined total of 0.5 milligrams of all other cannabinoids
28.11per serving; and
28.12 (3) do not contain an artificially derived cannabinoid other than delta-9
28.13tetrahydrocannabinol.
28.14 (b) If a lower-potency hemp edible is packaged in a manner that includes more than a
28.15single serving, the lower-potency hemp edible must indicate each serving by scoring,
28.16wrapping, or other indicators that appear on the lower-potency hemp edible designating the
28.17individual serving size. If it is not possible to indicate a single serving by scoring or use of
28.18another indicator that appears on the product, the lower-potency hemp edible may not be
28.19packaged in a manner that includes more than a single serving in each container, except
28.20that a calibrated dropper, measuring spoon, or similar device for measuring a single serving
28.21may be used for any edible cannabinoid products that are intended to be combined with
28.22food or beverage products prior to consumption. If the lower-potency hemp edible is meant
28.23to be consumed as a beverage, the beverage container may not contain more than two
28.24servings per container. If the lower-potency hemp edible is meant to be consumed as a
28.25beverage, the beverage container must not contain more than two servings.
28.26 (c) Notwithstanding paragraph (b), any edible cannabinoid products that are intended
28.27to be combined with food or beverage products before consumption must indicate a single
28.28serving using one of the following methods:
28.29 (1) the product is packaged in individual servings;
28.30 (2) the product indicates a single serving by scoring or use of another indicator that
28.31appears on the product; or
28.32 (3) the product is sold with a calibrated dropper, measuring spoon, or similar device for
28.33measuring a single serving.
28Sec. 41.
25-00281 as introduced02/19/25 REVISOR EB/VJ 29.1 (c) (d) A single package containing multiple servings of a lower-potency hemp edible
29.2must contain no more than 50 milligrams of delta-9 tetrahydrocannabinol, 250 milligrams
29.3of cannabidiol, 250 milligrams of cannabigerol, or any combination of those cannabinoids
29.4that does not exceed the identified amounts.
29.5 Sec. 42. Minnesota Statutes 2024, section 342.52, is amended by adding a subdivision to
29.6read:
29.7 Subd. 7a.Allowable delivery methods.A patient in the registry program may receive
29.8medical cannabis flower and medical cannabinoid products. The office may approve
29.9additional delivery methods to expand the types of products that qualify as medical
29.10cannabinoid products.
29.11Sec. 43. Minnesota Statutes 2024, section 342.57, subdivision 2, is amended to read:
29.12 Subd. 2.Criminal and civil protections.(a) Subject to section 342.56, the following
29.13are not violations of this chapter or chapter 152:
29.14 (1) use or possession of medical cannabis flower, medical cannabinoid products, or
29.15medical cannabis paraphernalia by a patient enrolled in the registry program or by a visiting
29.16patient to whom medical cannabis flower or medical cannabinoid products are distributed
29.17under section 342.51, subdivision 5;
29.18 (2) possession of medical cannabis flower, medical cannabinoid products, or medical
29.19cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or
29.20spouse of a patient enrolled in the registry program; or
29.21 (3) possession of medical cannabis flower, medical cannabinoid products, or medical
29.22cannabis paraphernalia by any person while carrying out duties required under sections
29.23342.51 to 342.60.
29.24 (b) The Office of Cannabis Management, members of the Cannabis Advisory Council,
29.25Office of Cannabis Management employees, agents or contractors of the Office of Cannabis
29.26Management, and health care practitioners participating in the registry program are not
29.27subject to any civil penalties or disciplinary action by the Board of Medical Practice, the
29.28Board of Nursing, or any business, occupational, or professional licensing board or entity
29.29solely for participating in the registry program either in a professional capacity or as a
29.30patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or
29.31disciplinary action by the Board of Pharmacy when acting in accordance with sections
29Sec. 43.
25-00281 as introduced02/19/25 REVISOR EB/VJ 30.1342.51 to 342.60 either in a professional capacity or as a patient. Nothing in this section
30.2prohibits a professional licensing board from taking action in response to a violation of law.
30.3 (c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the
30.4governor, or an employee of a state agency must not be held civilly or criminally liable for
30.5any injury, loss of property, personal injury, or death caused by any act or omission while
30.6acting within the scope of office or employment under sections 342.51 to 342.60.
30.7 (d) Federal, state, and local law enforcement authorities are prohibited from accessing
30.8the registry except when acting pursuant to a valid search warrant. Notwithstanding section
30.913.09, a violation of this paragraph is a gross misdemeanor.
30.10 (e) Notwithstanding any law to the contrary, the office and employees of the office must
30.11not release data or information about an individual contained in any report or document or
30.12in the registry and must not release data or information obtained about a patient enrolled in
30.13the registry program, except as provided in sections 342.51 to 342.60. Notwithstanding
30.14section 13.09, a violation of this paragraph is a gross misdemeanor.
30.15 (f) No information contained in a report or document, contained in the registry, or
30.16obtained from a patient under sections 342.51 to 342.60 may be admitted as evidence in a
30.17criminal proceeding, unless:
30.18 (1) the information is independently obtained; or
30.19 (2) admission of the information is sought in a criminal proceeding involving a criminal
30.20violation of sections 342.51 to 342.60.
30.21 (g) Possession of a registry verification or an application for enrollment in the registry
30.22program:
30.23 (1) does not constitute probable cause or reasonable suspicion;
30.24 (2) must not be used to support a search of the person or property of the person with a
30.25registry verification or application to enroll in the registry program; and
30.26 (3) must not subject the person or the property of the person to inspection by any
30.27government agency.
30.28Sec. 44. Minnesota Statutes 2024, section 342.59, subdivision 2, is amended to read:
30.29 Subd. 2.Allowable use; prohibited use.Data specified in subdivision 1 may be used
30.30to comply with chapter 13, to comply with a request from the legislative auditor or the state
30.31auditor in the performance of official duties, and for purposes specified in sections 342.47
30.32342.51 to 342.60. Data specified in subdivision 1 and maintained by the Office of Cannabis
30Sec. 44.
25-00281 as introduced02/19/25 REVISOR EB/VJ 31.1Management or Division of Medical Cannabis must not be used for any purpose not specified
31.2in sections 342.47 342.51 to 342.60 and must not be combined or linked in any manner
31.3with any other list, dataset, or database. Data specified in subdivision 1 must not be shared
31.4with any federal agency, federal department, or federal entity unless specifically ordered
31.5to do so by a state or federal court.
31.6 Sec. 45. Minnesota Statutes 2024, section 342.61, subdivision 4, is amended to read:
31.7 Subd. 4.Testing of samples; disclosures.(a) On a schedule determined by the office,
31.8every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
31.9manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
31.10hemp edible manufacturer, or medical cannabis combination business shall make each batch
31.11of cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency
31.12hemp edibles, or hemp-derived consumer products grown, manufactured, or imported by
31.13the cannabis business or hemp business available to a cannabis testing facility.
31.14 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis
31.15manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency
31.16hemp edible manufacturer, or medical cannabis combination business must disclose all
31.17known information regarding pesticides, fertilizers, solvents, or other foreign materials,
31.18including but not limited to catalysts used in creating artificially derived cannabinoids,
31.19applied or added to the batch of cannabis flower, cannabis products, artificially derived
31.20cannabinoids, lower-potency hemp edibles, or hemp-derived consumer products subject to
31.21testing. Disclosure must be made to the cannabis testing facility and must include information
31.22about all applications by any person, whether intentional or accidental.
31.23 (c) The A cannabis testing facility business shall select one or more representative
31.24samples from each batch, test the samples for the presence of contaminants, and test the
31.25samples for potency and homogeneity and to allow the cannabis flower, cannabis product,
31.26artificially derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer
31.27product to be accurately labeled with its cannabinoid profile. Testing for contaminants must
31.28include testing for residual solvents, foreign material, microbiological contaminants, heavy
31.29metals, pesticide residue, mycotoxins, and any items identified pursuant to paragraph (b),
31.30and may include testing for other contaminants. A cannabis testing facility must destroy or
31.31return to the cannabis business or hemp business any part of the sample that remains after
31.32testing.
31Sec. 45.
25-00281 as introduced02/19/25 REVISOR EB/VJ 32.1 Sec. 46. Minnesota Statutes 2024, section 342.63, subdivision 2, is amended to read:
32.2 Subd. 2.Content of label; cannabis.All cannabis flower and hemp-derived consumer
32.3products that consist of hemp plant parts sold to customers or patients must have affixed
32.4on the packaging or container of the cannabis flower or hemp-derived consumer product a
32.5label that contains at least the following information:
32.6 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
32.7cannabis cultivator, medical cannabis combination business, or industrial hemp grower
32.8where the cannabis flower or hemp plant part was cultivated;
32.9 (2) the net weight or volume of cannabis flower or hemp plant parts in the package or
32.10container;
32.11 (3) the batch number;
32.12 (4) the cannabinoid profile;
32.13 (5) a universal symbol established by the office indicating that the package or container
32.14contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
32.15hemp-derived consumer product;
32.16 (6) verification that the cannabis flower or hemp plant part was tested according to
32.17section 342.61 and that the cannabis flower or hemp plant part complies with the applicable
32.18standards;
32.19 (7) information on the usage of the cannabis flower or hemp-derived consumer product;
32.20 (8) the following statement: "Keep this product out of reach of children."; and
32.21 (9) any other statements or information required by the office.
32.22Sec. 47. Minnesota Statutes 2024, section 342.63, subdivision 3, is amended to read:
32.23 Subd. 3.Content of label; cannabinoid products.(a) All cannabis products,
32.24lower-potency hemp edibles, hemp concentrate, hemp-derived consumer products other
32.25than products subject to the requirements under subdivision 2, medical cannabinoid products,
32.26and hemp-derived topical products sold to customers or patients must have affixed to the
32.27packaging or container of the cannabis product a label that contains at least the following
32.28information:
32.29 (1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
32.30cannabis cultivator, medical cannabis combination business, or industrial hemp grower that
32.31cultivated the cannabis flower or hemp plant parts used in the cannabis product,
32Sec. 47.
25-00281 as introduced02/19/25 REVISOR EB/VJ 33.1lower-potency hemp edible, hemp-derived consumer product, or medical cannabinoid
33.2product;
33.3 (2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness,
33.4cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis
33.5combination business, or industrial hemp grower that manufactured the cannabis concentrate,
33.6hemp concentrate, or artificially derived cannabinoid and, if different, the name and license
33.7number of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer,
33.8lower-potency hemp edible manufacturer, or medical cannabis combination business that
33.9manufactured the product;
33.10 (3) the net weight or volume of the cannabis product, lower-potency hemp edible, or
33.11hemp-derived consumer product in the package or container;
33.12 (4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer
33.13product;
33.14 (5) the batch number;
33.15 (6) the serving size;
33.16 (7) the cannabinoid profile per serving and in total;
33.17 (8) a list of ingredients;
33.18 (9) a universal symbol established by the office indicating that the package or container
33.19contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a
33.20hemp-derived consumer product;
33.21 (10) a warning symbol developed by the office in consultation with the commissioner
33.22of health and the Minnesota Poison Control System that:
33.23 (i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
33.24 (ii) is in a highly visible color;
33.25 (iii) includes a visual element that is commonly understood to mean a person should
33.26stop;
33.27 (iv) indicates that the product is not for children; and
33.28 (v) includes the phone number of the Minnesota Poison Control System;
33.29 (11) verification that the cannabis product, lower-potency hemp edible, hemp-derived
33.30consumer product, or medical cannabinoid product was tested according to section 342.61
33Sec. 47.
25-00281 as introduced02/19/25 REVISOR EB/VJ 34.1and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product,
34.2or medical cannabinoid product complies with the applicable standards;
34.3 (12) information on the usage of the product;
34.4 (13) the following statement: "Keep this product out of reach of children."; and
34.5 (14) any other statements or information required by the office.
34.6 (b) The office may by rule establish alternative labeling requirements for lower-potency
34.7hemp edibles that are imported into the state if those requirements provide consumers with
34.8information that is substantially similar to the information described in paragraph (a).
34.9 Sec. 48. Minnesota Statutes 2024, section 342.63, subdivision 6, is amended to read:
34.10 Subd. 6.Additional information.(a) A cannabis microbusiness, cannabis mezzobusiness,
34.11cannabis retailer, or medical cannabis combination business must provide customers and
34.12patients with the following information:
34.13 (1) factual information about impairment effects and the expected timing of impairment
34.14effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products,
34.15lower-potency hemp edibles, and hemp-derived consumer products;
34.16 (2) a statement that customers and patients must not operate a motor vehicle or heavy
34.17machinery while under the influence of cannabis flower, cannabis products, lower-potency
34.18hemp edibles, and hemp-derived consumer products;
34.19 (3) resources customers and patients may consult to answer questions about cannabis
34.20flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
34.21products, and any side effects and adverse effects;
34.22 (4) contact information for the poison control center and a safety hotline or website for
34.23customers to report and obtain advice about side effects and adverse effects of cannabis
34.24flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer
34.25products;
34.26 (5) substance use disorder treatment options; and
34.27 (6) any other information specified by the office.
34.28 (b) A cannabis microbusiness, cannabis mezzobusiness, cannabis retailer, or medical
34.29cannabis combination business may include the information described in paragraph (a) by:
34Sec. 48.
25-00281 as introduced02/19/25 REVISOR EB/VJ 35.1 (1) including the information on the label affixed to the packaging or container of cannabis
35.2flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer products
35.3by:;
35.4 (1) (2) posting the information in the premises of the cannabis microbusiness, cannabis
35.5mezzobusiness, cannabis retailer, or medical cannabis combination business; or
35.6 (2) (3) providing the information on a separate document or pamphlet provided to
35.7customers or patients when the customer purchases cannabis flower, a cannabis product, a
35.8lower-potency hemp edible, or a hemp-derived consumer product.
35.9 Sec. 49. REPEALER.
35.10 Minnesota Statutes 2024, sections 152.22, subdivision 2; 342.01, subdivision 71; and
35.11342.151, subdivision 1, are repealed.
35Sec. 49.
25-00281 as introduced02/19/25 REVISOR EB/VJ 152.22 DEFINITIONS.
Subd. 2.Commissioner."Commissioner" means the commissioner of health.
342.01 DEFINITIONS.
Subd. 71.Visiting patient."Visiting patient" means an individual who is not a Minnesota
resident and who possesses a valid registration verification card or its equivalent that is issued under
the laws or regulations of another state, district, commonwealth, or territory of the United States
verifying that the individual is enrolled in or authorized to participate in that jurisdiction's medical
cannabis or medical marijuana program.
342.151 EMPLOYEES OF LICENSE HOLDERS.
Subdivision 1.Definitions.For purposes of this section, a "license holder" includes a cannabis
microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis
retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis event organizer,
cannabis delivery service, lower-potency hemp edible manufacturer, lower-potency hemp edible
retailer, or medical cannabis combination business.
1R
APPENDIX
Repealed Minnesota Statutes: 25-00281